Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Journal of Endocrinological Investigation
Erschienen in: Journal of Endocrinological Investigation 6/2014

01.06.2014 | Consensus Statement

Italian consensus for the classification and reporting of thyroid cytology

verfasst von: Francesco Nardi, Fulvio Basolo, Anna Crescenzi, Guido Fadda, Andrea Frasoldati, Fabio Orlandi, Lucio Palombini, Enrico Papini, Michele Zini, Alfredo Pontecorvi, Paolo Vitti

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Excerpt

Thyroid nodules are diagnosed with increasing frequency in clinical practice. The first step in the management of patients presenting with thyroid nodules is an accurate triage of those who should be referred to surgery [1‐5]. In spite of the advances in ultrasound (US) imaging [6‐8] and the promising results of molecular analysis [9‐16], this basic step still strongly relies on cytology [3]. Among the acronyms used to indicate the sampling technique for thyroid cytology (FNA, FNAB, FNAC, FNC), fine-needle aspiration (FNA) is the most frequently adopted and it will be employed in this document. When the cytologic specimen is obtained without aspiration the term FNC (fine-needle cytology) may be used [2]. …
Literatur
1.
Vitti P, Rago T, Elisei R et al (2008) Gestione clinica del paziente con patologia nodulare tiroidea: Consenso Italiano. L’Endocrinologo 9(Suppl. 4):S1–S16 (LoE n.a.)
2.
Fadda G, Basolo F, Bondi A et al (2010) Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica 102:405–408 (LoE n.a.)PubMed
3.
Gharib H, Papini E, Paschke R, AACE/AME/ETA Task Force on Thyroid Nodules et al (2010) American Association of clinical endocrinologists, Associazione Medici Endocrinologi, and European Thyroid association: Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 33(5):1–56 (LoE n.a.)CrossRef
4.
Cooper DS, Doherty GM, Haugen BR et al (2009) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214 (LoE n.a.)PubMedCrossRef
5.
Ross DS (2002) Nonpalpable thyroid nodules—managing an epidemic. J Clin Endocrinol Metab 87:1938–1940 (LoE n.a.)PubMed
6.
Moon WJ, Jun Moon WJ, Baek JH et al (2011) Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 12:1–14 (LoE n.a.)PubMedCentralPubMedCrossRef
7.
Bastin S, Bolland MJ, Croxson MS (2009) Role of ultrasound in the assessment of nodular thyroid disease. J Med Imaging Radiat Oncol. 53:177–187 (LoE n.a.)PubMedCrossRef
8.
Sipos JA (2009) Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid 19:1363–1372 (LoE n.a.)PubMedCrossRef
9.
Bartolazzi A, Orlandi F, Saggiorato E et al (2008) Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 95:43–49 (LoE ⊗ ⊗ ◯)
10.
Fadda G, Rossi ED, Raffaelli M et al (2011) Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol 165:447–453 (LoE ⊗ ⊗◯)PubMedCrossRef
11.
Cantara S, Capezzone M, Marchisotta S et al (2010) Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95:1365–1369 (LoE ⊗ ⊗◯)PubMedCrossRef
12.
Nikiforov YE, Steward DL, Robinson-Smith TM et al (2009) Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092–2098 (LoE ⊗ ⊗◯)PubMedCrossRef
13.
Chudova D, Wilde JI, Wang ET et al (2010) Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 95:5296–5304 (LoE ⊗ ⊗◯)PubMedCrossRef
14.
Alexander EK, Kennedy GC, Baloch ZW et al (2012) Preoperative diagnosis of thyroid nodules with indeterminate cytology. N Engl J Med 367:705–715 (LoE ⊗ ⊗◯)PubMedCrossRef
15.
Kloos R, Reynolds JD, Walsh PS et al (2013) Does addition of BRAF V600E molecular testing modify sensitivity or specificity of the Afirma gene expression classifier in cytologically indeterminate thyroid nodules? J Clin Endocrinol Metab 98:E761–E768 (LoE ⊗ ⊗◯)PubMedCrossRef
16.
Tonacchera M, Agretti P, Rago T et al (2012) Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency. J Endocrinol Invest 35:754–759PubMed
17.
Jing X, Michael CW, Pu RT (2008) The clinical and diagnostic impact of using standard criteria of adequacy assessment and diagnostic terminology on thyroid nodule fine needle aspiration. Diagn Cytopathol 36:161–166 (LoE ⊗ ◯◯)PubMedCrossRef
18.
Baloch ZW, LiVolsi VA, Asa SL et al (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425–437 (LoE n.a.)PubMedCrossRef
19.
Ali SZ, Cibas ES (2010) The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes. Springer, New York (LoE n.a.)CrossRef
20.
Kocjan G, Cochand-Priollet B, de Agustin PP et al (2010) Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology 21:86–92 (LoE n.a.)PubMedCrossRef
21.
British Thyroid Association Royal College of Physicians (2007) Guidelines for the management of thyroid cancer. In: Perros P (ed.) Report of the Thyroid Cancer Guidelines Update Group. Royal College of Physicians, London, UK, 2nd edition (LoE n.a.)
22.
23.
24.
Atkins D, GRADE Working Group et al (2004) Grading quality of evidence and strength of recommendations. Br Med J 328:1490 (LoE n.a.)CrossRef
25.
Swiglo BA, Murad MH, Schünemann HJ et al (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666–673 (LoE n.a.)PubMedCrossRef
26.
Frates MC, Benson CB, Charboneau JW et al (2005) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 237:794–800 (LoE n.a.)PubMedCrossRef
27.
Kim MJ, Kim EK, Park SI et al (2008) US-guided fine needle aspiration of thyroid nodules: indications, techniques, results. Radiographics 28:1869–1886PubMedCrossRef
28.
Park JM, Choi Y, Kwag HJ (2012) Partially cystic thyroid nodules: ultrasound findings of malignancy. Korean J Radiol 13:530–535 (LoE ⊗ ◯◯)PubMedCentralPubMedCrossRef
29.
Lee MJ, Kim EK, Kwak JY, Kim MJ (2009) Partially cystic thyroid nodules on ultrasound: probability of malignancy and sonographic differentiation. Thyroid 19:341–346 (LoE ⊗ ⊗◯)PubMedCrossRef
30.
Sohn YM, Yoon JH, Moon HJ, Kim EK, Kwak JY (2012) Mixed echoic thyroid nodules on ultrasound: approach to management. Yonsei Med J 53:812–819 (LoE ⊗ ◯◯)PubMedCentralPubMedCrossRef
31.
Pitman MB, Abele J, Ali SZ et al (2008) Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:407–424 (LoE n.a.)PubMedCrossRef
32.
Bibbo M, Wilbur DC (2008) Comprehensive Cytopathology, 3rd Edition. Saunders, Elsevier (LoE n.a.)
33.
Park KT, Ahn SH, Mo JH et al (2011) Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head Neck 33:160–165 (LoE ⊗ ⊗◯)PubMedCrossRef
34.
Na DG, Kim JH, Sung JY et al (2012) Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. Thyroid 22:468–475 (LoE ⊗ ⊗◯)PubMedCrossRef
35.
Samir AE, Vij A, Seale MK et al (2012) Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate. Thyroid 22:461–467 (LoE ⊗ ⊗◯)PubMedCentralPubMedCrossRef
36.
Fadda G, Rossi ED (2011) Liquid-based cytology in fine-needle aspiration biopsies of the thyroid gland. Acta Cytol 55:389–400 (LoE ⊗ ◯◯)PubMedCrossRef
37.
Rossi ED, Raffaelli M, Zannoni GF et al (2009) Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases. Acta Cytol 53:659–666PubMedCrossRef
38.
Nasrollah N, Trimboli P, Guidobaldi L (2013) Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine 43:659–665 (LoE ⊗ ◯◯)PubMedCrossRef
39.
Gharib H, Goellner JR, Johnson DA (1993) Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med 13:699–709 (LoE n.a.)PubMed
40.
Nasuti JF, Gupta PK, Baloch ZW (2002) Diagnostic value and cost-effectiveness of on site evaluation of fine needle aspiration specimens: Review of 5,688 cases. Diagn Cytopatol 27:1–4 (LoE ⊗ ◯◯)CrossRef
41.
Goellner JR, Gharib H, Grant CS, Johnson DA (1987) Fine needle aspiration cytology of the thyroid, 1980–1986. Acta Cytol 31:587–590 (LoE ⊗ ◯◯)PubMed
42.
Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 56:333–339 (LoE ⊗ ⊗ ⊗)PubMedCrossRef
43.
Bongiovanni M, Crippa S, Baloch Z et al (2012) Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol 120:117–125 (LoE ⊗ ⊗◯)PubMedCrossRef
44.
Nou E, Kwong N, Alexander LK, et al (2014) Determination of the optimal time interval for repeat evaluation following a benign thyroid nodule aspiration. J Clin Endocrinol Metab 99:510–516 (LoE ⊗ ⊗◯)
45.
Piana S, Frasoldati A, Ferrari M et al (2011) Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18000 FNAs reported at the same institution during 1998–2007. Cytopathology 22:164–173 (LoE ⊗ ⊗◯)PubMedCrossRef
46.
Pagni F, Prada M, Goffredo P, et al (2013) Indeterminate for malignancy (Tir3/Thy3 in the Italian and British system for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphologic criteria and clinical impact Cytopathology: 1–7 (Epub) (LoE ⊗ ⊗◯)
47.
Rago T, Di Coscio G, Basolo F et al (2007) Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hurthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 66:13–20 (LoE ⊗ ⊗◯)
48.
Renshaw AA (2010) Should “atypical follicular cells” in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 118:186–189 (LoE ⊗ ⊗◯)PubMedCrossRef
49.
Vanderlaan PA, Marqusee E, Krane JF (2011) Usefulness of diagnostic qualifiers for thyroid, fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol 136:572–577 (LoE ⊗ ⊗◯)PubMedCrossRef
50.
Alexander EK (2008) Approach to the patient with a cytologically indeterminate thyroid nodule. J Clin Endocrinol Metab 93:4175–4182 (LoE n.a.)PubMedCrossRef
51.
Yoon JH, Kwak JY, Kim EK et al (2010) How to approach thyroid nodules with indeterminate cytology. Ann Surg Oncol 17:2147–2155 (LoE ⊗ ⊗◯)PubMedCrossRef
52.
Faquin WC, Baloch ZW (2010) Fine-Needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 38:731–739 (LoE ⊗ ⊗◯)PubMed
53.
Yang J, Schnadig V, Logrono R, Wasserman PG (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 5:306–315 (LoE ⊗ ⊗◯)CrossRef
54.
Yoder BJ, Redman R, Massoll NA (2006) Validation of a five-tier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation. Thyroid 16:781–786 (LoE ⊗ ⊗◯)PubMedCrossRef
Metadaten
Titel
Italian consensus for the classification and reporting of thyroid cytology
verfasst von
Francesco Nardi
Fulvio Basolo
Anna Crescenzi
Guido Fadda
Andrea Frasoldati
Fabio Orlandi
Lucio Palombini
Enrico Papini
Michele Zini
Alfredo Pontecorvi
Paolo Vitti
Publikationsdatum
01.06.2014
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 6/2014
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0062-0

Weitere Artikel der Ausgabe 6/2014

Journal of Endocrinological Investigation 6/2014 Zur Ausgabe

Original Article

Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus

Original Article

Gynecomastia in subjects with sexual dysfunction

Original Article

Variants of 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents

Original Article

Serum 25 hydroxyvitamin D in employees of a Middle Eastern university hospital

Original Article

Role of protein kinase C β2 in relaxin-mediated inhibition of cardiac fibrosis

Opinion

Serum-negative autoimmune thyroiditis: what’s in a name?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise